GT Biopharma (GTBP) Interest & Investment Income (2009 - 2026)
GT Biopharma's Interest & Investment Income was $58,000 in Q2 2026, up 52.6% from $38,000 a year earlier but down 13.4% from the prior quarter.
GT Biopharma (GTBP) Interest & Investment Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, GT Biopharma's Interest & Investment Income was $178,000 through Jun 30, 2026, down 20.9% year-over-year; for FY2025, it was $123,000, down 69.4% from FY2024.
- Interest & Investment Income shows a four-year compound annual growth rate of 34.1% (FY2021 to FY2025).
- In earlier years, Interest & Investment Income was $402,000 in FY2024 (-48.5%), $780,000 in FY2023 (+167.1%), $292,000 in FY2022 (+668.4%) and $38,000 in FY2021.
- Quarterly Interest & Investment Income has moved between -$107,000 (Q3 2022) and $443,000 (Q4 2022) over five years.
- Compared with a year earlier, Interest & Investment Income was higher in two of the last eight quarters, with an average decline of 29.5%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q1 2026 (growth of 109.4%); the worst was Q1 2025 (a decline of 77.5%).
- Per Business Quant data, GTBP's Interest & Investment Income in the three quarters before Q2 2026 was $67,000 (Q1 2026), $17,000 (Q4 2025) and $36,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 58,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 59,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 142,000.00 |
| Dec 31, 2023 | 180,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 220,000.00 |
| Mar 31, 2023 | 164,000.00 |
| Dec 31, 2022 | 443,000.00 |
| Sep 30, 2022 | -107,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 32,000.00 |
GT Biopharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();